News

First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level

View more

Dec 15, 2023

SUO 2023: PSMA PET/CT-Detected Mesorectal Nodal Metastasis in Biochemically Recurrent Prostate Cancer Patients

View more

Dec 15, 2023

177Lu-PSMA-617 tolerable in patients with mCRPC and baseline cytopenias

View more

Dec 15, 2023

BPH-Related False Positive Rate on PSMA-PET for Prostate Cancer Quantified

View more

Dec 08, 2023

F-18 fluciclovine PET/CT detects metastatic breast cancer

View more

Dec 08, 2023

Study compares 18F-based PSMA radiotracers to [68Ga]Ga-PSMA-11

View more

Dec 08, 2023